EuroPCR 2019 | Most Recent TAVR Meta-Analysis: The Spectrum of Treatment Reaches All Patients

This new meta-analysis combines all randomized transcatheter aortic valve replacement (TAVR) vs. surgical aortic valve replacement trials and expands the scope of TAVR.

Evidence across the range of risk studied supports a paradigm shift in patients with symptomatic severe aortic stenosis.

The clinical superiority of TAVR compared with surgery has been demonstrated across the spectrum of risk, which, consequently, should not guide the choice between these treatment strategies.

This meta-analysis, presented at EuroPCR and simultaneously published in the European Heart Journal, combines over 8000 patients who have been enrolled to date in 7 randomized controlled trials, from the earliest high-risk or inoperable patient trials to the most recently released studies, PARTNER 3 and Evolut TAVR in Low-Risk Patients.


Read also: EuroPCR 2019 | Leaflex: New Device for Pre-TAVR Calcium Fracture.


Beyond patient risk and regardless of valve type, TAVR was associated with a significant reduction in all-cause mortality as compared with surgery (hazard ratio [HR]: 0.88; 95% confidence interval [CI]: 0.78-0.99). The rate of stroke also favored TAVR, unlike the rates for vascular complications and pacemaker implantations.

In an analysis that only included patients treated using transfemoral access, mortality was reduced by 17% at 2 years with TAVR (HR: 0.83; 95% CI: 0.72-0.94).

Hospital costs are also reduced due to lower procedure times, reduced intensive care unit stays, and reduced total hospital stays. Costs, however, may change significantly depending on the country.

The EuroPCR statement concludes that TAVR should now be the strategy of choice, with a heart team weighing the individual clinical and anatomical characteristics of patients.


Read also: EuroPCR 2019 | EFFPAC: New Peripheral Paclitaxel Coated Balloons, Efficacy with no Sign of Mortality.


There still are a number of uncertainties, including those related to durability, bicuspid valve disease, younger patients, treatment of concomitant coronary artery disease, and best antithrombotic strategy.

metaanalisis-TAVI-europcr

Original Title: Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis.

Reference: Siontis GCM et al. Eur Heart J. 2019; Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

Multicenter Experience with 3D Intracardiac Echocardiography for Guiding Interventional Cardiac Procedures

Courtesy of Dr. Juan Manuel Pérez. Imaging techniques play a fundamental role in interventional cardiac procedures. Intracardiac echocardiography (ICE) appears as an alternative to transesophageal...

Pathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening

Courtesy of Dr. Juan Manuel Pérez. Despite the available long term followup data on of transcatheter aortic valve replacement (TAVR), bioprosthesis durability continues under debate....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...